Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006089
Status:
COMPLETED
Last Update Posted:
2019-07-31
First Post:
2000-08-03
Brief Title:
Trastuzumab in Treating Patients With Stage III Stage IV or Recurrent Endometrial Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Uterine Corpus Cancer AJCC v7 |
| Endometrial Adenocarcinoma |
| ERBB2 Gene Amplification |
| Recurrent Uterine Corpus Carcinoma |
| Stage III Uterine Corpus Cancer AJCC v7 |
Keywords: